Navigation Links
GlaxoSmithKline and Pfizer Announce Innovative Agreement to Create a New World-Leading, Specialist HIV Company
Date:4/16/2009

Business Unit, Europe, Pfizer
  • Zhi Hong, SVP and Head of Infectious Diseases CEDD, GSK
  • Abbas Hussain, President Emerging Markets, GSK
  • Duncan Learmouth, SVP Corporate Communications & Community Partnerships, GSK
  • Martin Mackay, President, Global Research & Development, Pfizer
  • Ian McCubbin, SVP Strategy, Logistics and External Supply, GSK
  • Ellen Strahlman, SVP and Chief Medical Officer, GSK

  • GSK and Pfizer have established an integration steering committee, with representatives from both companies to prepare for the operation of the new company upon the closing of the transaction. A head of R&D will be appointed to oversee all research and development activities. Manufacturing and other services will be provided by GSK and Pfizer.

    Financial details

    The combination is highly complementary and serves both companies strategically. For GSK, the transaction will expand its marketed portfolio, helping to reduce the impact of patent expiries to several of its HIV products in future years, and it will provide access to a broad range of new pipeline assets. For Pfizer, the collaboration will provide Selzentry/Celsentri and its pipeline assets with access to GSK's global HIV commercial organisation and HIV distribution network to better reach patients in need.

    Equity interests

    Upon completion of the transaction, GSK will hold an 85% equity interest in the new company and Pfizer will hold 15% reflecting the value of their currently marketed products. To reflect the potential future performance of their respective HIV pipeline products, GSK and Pfizer have agreed a structure for their equity interests to be adjusted in the event that specified sales and regulatory milestones are achieved.

    If all milestones were to be achieved, GSK's equity interest in th
    '/>"/>

    SOURCE GlaxoSmithKline plc
    Copyright©2009 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8 9

    Related medicine news :

    1. GlaxoSmithKline and Shire Enter Agreement to Co-Promote Vyvanse(R) (lisdexamfetamine dimesylate) CII for Adult Attention Deficit Hyperactivity Disorder
    2. IADR and GlaxoSmithKline Consumer Healthcare announce winners of 2009 Innovation in Oral Care Awards
    3. GlaxoSmithKline Consumer Healthcare to Reach 85 Percent of the Worlds Smokers with Quit Aids
    4. GlaxoSmithKline Consumer Healthcare Helps to Bridge Oral Care Gap in Appalachia
    5. Activplant Corporation Announces Global Agreement with GlaxoSmithKline
    6. GlaxoSmithKline and Genmab Submit Arzerra(TM) (Ofatumumab) Application to FDA for the Treatment of Advanced Stage Blood Cancer
    7. GlaxoSmithKlines Drug Will Become New Clinical Gold Standard by 2012 for the Treatment of Relapsed/Refractory CLL
    8. GlaxoSmithKline Awards Ten Area Healthcare Nonprofits with $40,000 Each in Funding
    9. GlaxoSmithKline and Dynavax Announce Worldwide Strategic Alliance : – Developing First-in-Class Endosomal TLR Inhibitors for Autoimmune and Inflammatory Diseases –
    10. GlaxoSmithKline Statement on FDA Advisory Committee Vote on Use of Asthma Medicines Containing Long-Acting Beta-Agonists
    11. GlaxoSmithKline and The Carter Center Reaffirm Commitment to Global Public Health with Expansion of LF Program
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:9/20/2014)... NV (PRWEB) September 21, 2014 ... method developed by fitness expert Michael Wren that has ... stubborn weight and reverse health conditions like high blood ... attention of Shane Michaels, prompting an investigative review. ... methods and tips upside down by showing people what ...
    (Date:9/20/2014)... 2014 Villa del Palmar at the ... experience any damage in relation to Hurricane Odile and ... , Hurricane Odile struck Cabo San Lucas the night ... powerful surf conditions. Located on the east side of ... experienced some heavy rain, but no damage whatsoever to ...
    (Date:9/20/2014)... 20, 2014 On Monday, September 22, ... pediatric cancer research grant from Hyundai Hope on Wheels ... Children’s Hospital located on 11234 Anderson St., in Loma ... Kimberley Payne, Associate Professor at Loma Linda University and ... leukemia in children. , Loma Linda University ...
    (Date:9/20/2014)... Sept. 19, 2014 (HealthDay News) -- The avian flu ... 2011 could be spread through respiratory drops and therefore ... new study. Although no human illnesses have been ... Jude Children,s Research hospital have discovered natural mutations to ... to travel through the air in droplets. Current ...
    (Date:9/20/2014)... New PharmaPoint Drug Evaluation report, “Symbicort ... The asthma market saw very slow growth over ... with relatively efficacious standard therapies, such as short-acting ... long-acting beta-agonists (ICS/LABAs), and leukotriene modifiers, and has ... launch of seven novel targeted biologic agents and ...
    Breaking Medicine News(10 mins):Health News:Weight Destroyer: Review Exposes Michael Wren’s Guide to Effective Weight Loss and Improved Health 2Health News:Weight Destroyer: Review Exposes Michael Wren’s Guide to Effective Weight Loss and Improved Health 3Health News:Villa del Palmar at the Islands of Loreto Fully Functioning After Hurricane 2Health News:Villa del Palmar at the Islands of Loreto Fully Functioning After Hurricane 3Health News:Loma Linda University Medical Center Receives $250,000 Research Grant From Hyundai Hope On Wheels In Honor Of National Childhood Cancer Awareness Month 2Health News:Loma Linda University Medical Center Receives $250,000 Research Grant From Hyundai Hope On Wheels In Honor Of National Childhood Cancer Awareness Month 3Health News:Avian Flu In Harbor Seals Could Infect People 2Health News:Symbicort Asthma Market Forecasts to 2023 - Overview, Efficacy, Safety & SWOT Analysis in New Report Available at LifeScienceIndustryResearch.com 2Health News:Symbicort Asthma Market Forecasts to 2023 - Overview, Efficacy, Safety & SWOT Analysis in New Report Available at LifeScienceIndustryResearch.com 3Health News:Symbicort Asthma Market Forecasts to 2023 - Overview, Efficacy, Safety & SWOT Analysis in New Report Available at LifeScienceIndustryResearch.com 4
    ... Harvard Graduate School of Education (HGSE) will ... leaders, practitioners and faculty improve educational practices through greater ... Brain, and Education institute will explore how advances ... functions can improve the educational process. Information about ...
    ... does speciation the evolutionary process that results in the formation ... contributed to our understanding of speciation? , Evolutionary biologist David ... will give at UC Riverside at 7 p.m., Thursday, April 30, ... title of his talk is "The Evolution of Evolution: Darwin Then ...
    ... sales in Russia, Brazil, and India will shrink by ... WALTHAM, Mass., April 23 According to Millennium ... markets in Brazil, India, and Russia, the global economic ... markets in these 3 countries in 2009, particularly for ...
    ... 23 Kendle (Nasdaq: KNDL ) announced ... financial results after the market closes on Wednesday, May ... call and simultaneous webcast on Thursday, May 7 at ... will follow.(Logo: http://www.newscom.com/cgi-bin/prnh/20080923/CLTU095LOGO ...
    ... Court for the District of Massachusetts has preliminarily approved ... large drug wholesaler. The lawsuit, called New ... concerns the pricing of more than 450 brand-name ... money back. Prescription drugs are ...
    ... facilities offering weight loss surgery, more people choosing ... offering surgical weight loss programs have increased dramatically ... important than ever to know which ones produce ... undergoing weight loss surgery at facilities designated as ...
    Cached Medicine News:Health News:Bringing Brain Science to the Classroom 2Health News:How new species evolve is focus of public lecture at UC Riverside 2Health News:How new species evolve is focus of public lecture at UC Riverside 3Health News:Emerging Markets for Diagnostic Imaging Systems Hurt by Economic Crisis 2Health News:Kendle Announces First Quarter 2009 Earnings Conference Call and Webcast 2Health News:Proposed $350 Million Class Action Settlement Regarding Drug Pricing Provides Consumers and Third-Party Payors With Money Back 2Health News:Patients Had Fewer Infection Rates, Fewer Complications at Blue Distinction Centers for Bariatric Surgery(R), According to HealthCore Study 2Health News:Patients Had Fewer Infection Rates, Fewer Complications at Blue Distinction Centers for Bariatric Surgery(R), According to HealthCore Study 3Health News:Patients Had Fewer Infection Rates, Fewer Complications at Blue Distinction Centers for Bariatric Surgery(R), According to HealthCore Study 4
    (Date:9/19/2014)... Sept. 19, 2014  4WEB Medical announces the formal ... and ankle osteotomy implants on the market today ... annual meeting in Chicago .  The ... a surgeon,s osteotomy needs with 74 size options included in ... offerings of only 15 to 18 implant sizes, which ...
    (Date:9/19/2014)... -- UBM Medica US announces that  OncoTherapy ... oncologists and other clinicians gain a better understanding of ... therapies and immunotherapies, discusses some of the latest news ... Every September, Blood Cancer Awareness Month is ... cancers—helping to increase survival rates and improve the quality ...
    (Date:9/19/2014)... SOUTH EASTON, Mass. , Sept. 19, 2014 ... the "Company") today announced it has received and ... throughput Barozyme HT48 instruments and has begun to ... believes the first instrument will be ready for ... will be built and released at a rate ...
    Breaking Medicine Technology:4WEB Medical Unveils 3D-Printed Osteotomy Truss System 2OncoTherapy Network Highlights National Blood Cancer Awareness Month 2OncoTherapy Network Highlights National Blood Cancer Awareness Month 3OncoTherapy Network Highlights National Blood Cancer Awareness Month 4Pressure BioSciences Announces Completion of the First Phase of Its Commercialization Plan for the Barozyme HT48, the Company's Recently Released High Throughput PCT-based Instrument System 2Pressure BioSciences Announces Completion of the First Phase of Its Commercialization Plan for the Barozyme HT48, the Company's Recently Released High Throughput PCT-based Instrument System 3
    ... 7, 2011 CareFusion Corporation (NYSE: ... today the appointment of Carlos M. Nunez, M.D. as its ... an anesthesiologist, intensivist and hospitalist as well as an experienced ... business career in the areas of clinical effectiveness, information technology, ...
    ... CHICAGO, March 7, 2011 General Nutrition Company (GNC) ... products manufacturer Sakar International for a line of more ... line,s initial merchandise offerings will range from heart rate ... and electronic pill boxes. The products ...
    Cached Medicine Technology:CareFusion Appoints Carlos M. Nunez, M.D. as Chief Medical Officer 2GNC Teams With Sakar International for Branded Health and Wellness Product Line 2GNC Teams With Sakar International for Branded Health and Wellness Product Line 3
    ... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
    ... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
    ... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
    ... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
    Medicine Products: